Algert Global LLC Purchases Shares of 34,430 Teladoc Health, Inc. (NYSE:TDOC)

Algert Global LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 34,430 shares of the health services provider's stock, valued at approximately $313,000.

Other large investors also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new stake in shares of Teladoc Health in the fourth quarter valued at approximately $29,000. Lindbrook Capital LLC increased its stake in shares of Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after acquiring an additional 1,612 shares during the period. Sterling Capital Management LLC increased its stake in shares of Teladoc Health by 776.7% during the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after acquiring an additional 4,101 shares during the period. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Teladoc Health during the fourth quarter valued at approximately $60,000. Finally, Generali Investments Management Co LLC acquired a new position in shares of Teladoc Health during the fourth quarter valued at approximately $64,000. Institutional investors and hedge funds own 76.82% of the company's stock.

Teladoc Health Stock Up 3.8%

Shares of Teladoc Health stock traded up $0.27 during midday trading on Friday, reaching $7.52. 4,601,008 shares of the company's stock traded hands, compared to its average volume of 6,252,450. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -1.30 and a beta of 1.82. The company's 50 day simple moving average is $7.58 and its 200 day simple moving average is $9.37. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a 52 week low of $6.35 and a 52 week high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.58% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Canaccord Genuity Group reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Bank of America reduced their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a report on Friday, April 11th. Evercore ISI reduced their target price on shares of Teladoc Health from $8.00 to $7.00 and set an "in-line" rating for the company in a report on Thursday, May 1st. The Goldman Sachs Group decreased their price objective on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, May 1st. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $9.71.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.